RESUMO
Preliminary screening of antiviral AIDS drugs has been carried out using three different in vitro assay systems. Among 96 samples of different origin tested, two were shown to inhibit the growth of HIV in vitro. One of the positive samples (plant origin) has hopeful signs, as the ranges of effective doses are wider than those of most of positive samples which had been found by us.
Assuntos
Síndrome da Imunodeficiência Adquirida/tratamento farmacológico , Fármacos Anti-HIV/farmacologia , Avaliação Pré-Clínica de Medicamentos/métodosRESUMO
We examined local effects of basic fibroblast growth factor (bFGF) on early bronchial revascularization following bronchial anastomosis. The left main bronchi of mongrel dogs (8-15 kg) were cut and sutured following peripheral radical hilar stripping. The anastomotic sites were wrapped with a pericardial fat tissue pedicle, including branches of the internal thoracic artery and vein (8 dogs group A). One ml of bFGF (Biomedical Tecnologies Inc.) dissolved in 1 ml of fibrin glue (final concentration of 20 ng/ml for a total dose of 100 ng, pH 7.15-7.5) was applied to the anastomotic sites in order to deliver the bFGF gradually and selectively (12 dogs group B). At various timepoints, changes in bronchial mucosal blood flow were measured using a laser Doppler flowmeter and left internal thoracic artery (LITA) blood flow, using an implanted electromagnetic flowmeter. On the 7th postoperative day, silicone rubber was injected into the left subclavian artery, and the revascularization pattern from branches of the LITA to the bronchus was examined histologically. Specimens were labeled as (-) when the neogenic vessels were only observed outside the bronchial wall, (1+) when observed inside the bronchial wall but not in the mucosa, and (2+) when clearly observed in the mucosa. Blood flow in the bronchial mucosa was measured as the left/right ratio. For group A, the averages immediately after operation, and on the 3rd and on the 7th postoperative days, were 0.35 +/- 0.10, 0.46 +/- 0.04, and 0.70 +/- 0.14 respectively; while, for group B, they were 0.27 +/- 0.09, 0.78 +/- 0.15, and 0.90 +/- 0.15, respectively (p < 0.01). Our results show that blood flow in the LITA increased more in group B than in group A (average 2.7 +/- 1.8 ml/min in group A, vs. 4.7 +/- 2.9 ml/min in group B). Furthermore, the pathologic findings of neovascularization were (-) in 3 cases and (1+) in 2 cases in group A, while group B showed (1+) neovascularization in 1 case and (2+) in 4 cases. These results clearly demonstrate increased revascularization in the bFGF treatment group B. We conclude that local application of bFGF is effective in stimulating early bronchial revascularization.
Assuntos
Brônquios/irrigação sanguínea , Brônquios/cirurgia , Fator 2 de Crescimento de Fibroblastos/uso terapêutico , Anastomose Cirúrgica , Animais , Cães , Adesivo Tecidual de Fibrina/uso terapêutico , Fator 2 de Crescimento de Fibroblastos/farmacologia , Mucosa/irrigação sanguínea , Fluxo Sanguíneo Regional/efeitos dos fármacosRESUMO
Preliminary screening of antiviral AIDS drugs has been carried out using three different in vitro assay systems. Among 191 samples tested, seven were found to inhibit the growth of HIV in vitro. Four of seven have hopeful signs, as the ranges of effective doses of the samples are wide.
Assuntos
Antivirais/farmacologia , HIV/efeitos dos fármacos , Células Cultivadas , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Resistência Microbiana a Medicamentos , Humanos , Testes de Sensibilidade MicrobianaRESUMO
Preliminary screening for antiviral AIDS drugs has been carried out, using three different in vitro assay systems. Among 105 samples tested, 13 were found to inhibit the growth of HIV in vitro. Eleven of 13 were well-known anti-HIV chemicals, while the remaining two of plant origin were new chemicals whose anti-HIV activities have not been reported elsewhere.
Assuntos
Antivirais/farmacologia , Avaliação Pré-Clínica de Medicamentos/métodos , HIV-1/efeitos dos fármacos , Testes de Sensibilidade Microbiana/métodosRESUMO
The serum antibodies to human immunodeficiency virus types 1 (HIV-1) and 2 (HIV-2) were examined for among individuals who visited health centers in Tokyo. Of 8,198 sera screened, one was true-positive and 37 false-positive for HIV-1 antibodies. These 37 false-positives and 305 sera from the population groups at risk for HIV-2 (42 sojourners in Africa, 251 homo- and bisexuals, and 19 prostitutes) were further examined for HIV-2 antibodies by indirect immunofluorescence and Western blotting. No antibodies reactive with HIV-2 were detected in the sera examined. Serological cross-reactivity between HIV-1 and HIV-2 was examined by use of rabbit antisera.